A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies

Name: A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
License: Public Domain

Amgen

ClinicalTrials.gov · Datasets · License: Public Domain

relapsed/refractory aml, minimal residual disease positive aml, myelodysplastic syndrome

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 245529
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.